Case report of primary CD20 negative diffuse large B-cell lymphoma
Open Access
- 25 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2021 (11-12) , 447-449
Abstract
Few groups of aggressive non-Hodgkin’s lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.Keywords
This publication has 14 references indexed in Scilit:
- SOX11 is a biomarker for cyclin D1-negative mantle cell lymphomaBiomarker Research, 2016
- A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemiaBiomarker Research, 2016
- Progression of a hepatosplenic gamma delta T‐cell leukemia/lymphoma on hyperCVAD/MTXand ara‐C: literature review and our institutional treatment approachClinical Case Reports, 2015
- CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 casesTumor Biology, 2015
- The BCL2 antagonist ABT‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4Wild‐type and CXCR4WHIM mutated Waldenstrom macroglobulinaemia cellsBritish Journal of Haematology, 2015
- Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA GroupBritish Journal of Haematology, 2014
- CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosisAmerican Journal of Hematology, 2014
- Peptides as targeting probes against tumor vasculature for diagnosis and drug deliveryJournal of Translational Medicine, 2012
- CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: A matched case-control analysis in a single institutionJournal of Translational Medicine, 2012
- The immune score as a new possible approach for the classification of cancerJournal of Translational Medicine, 2012